Search Results - "Medina, Jesús R."

Refine Results
  1. 1
  2. 2
  3. 3

    Selective 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitors: dissecting the function and pharmacology of PDK1 by Medina, Jesús R

    Published in Journal of medicinal chemistry (11-04-2013)
    “…3-Phosphoinositide-dependent protein kinase 1 (PDK1) is a protein target that has generated considerable interest in both academia and the pharmaceutical…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Selective 3‑Phosphoinositide-Dependent Kinase 1 (PDK1) Inhibitors: Dissecting the Function and Pharmacology of PDK1: Miniperspective by Medina, Jesús R

    Published in Journal of medicinal chemistry (11-04-2013)
    “…3-Phosphoinositide-dependent protein kinase 1 (PDK1) is a protein target that has generated considerable interest in both academia and the pharmaceutical…”
    Get full text
    Journal Article
  6. 6
  7. 7

    High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells by Kallal, Lorena A, Waszkiewicz, Anna, Jaworski, Jon-Paul, Della Pietra, Anthony, Berrodin, Tom, Brady, Pat, Jurewicz, Anthony J, Zeng, Xin, Payne, Lisa, Medina, Jesús R, Doepner-Buser, Carolyn, Mangatt, Biju

    Published in SLAS discovery (01-02-2021)
    “…While c-MYC is well established as a proto-oncogene, its structure and function as a transcription factor have made c-MYC a difficult therapeutic target. To…”
    Get more information
    Journal Article
  8. 8

    9-Borabicyclo[3.3.2]decanes and the Asymmetric Hydroboration of 1,1-Disubstituted Alkenes by Gonzalez, Ana Z, Román, José G, Gonzalez, Eduvigis, Martinez, Judith, Medina, Jesus R, Matos, Karl, Soderquist, John A

    Published in Journal of the American Chemical Society (23-07-2008)
    “…The syntheses of the optically pure asymmetric hydroborating agents 1 (a, R = Ph; b, R = TMS) in both enantiomeric forms are reported. These reagents are…”
    Get full text
    Journal Article
  9. 9

    Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery by Medina, Jesús R, Blackledge, Charles W, Heerding, Dirk A, Campobasso, Nino, Ward, Paris, Briand, Jacques, Wright, Lois, Axten, Jeffrey M

    Published in ACS medicinal chemistry letters (11-11-2010)
    “…Fragment screening of phosphoinositide-dependent kinase-1 (PDK1) in a biochemical kinase assay afforded hits that were characterized and prioritized based on…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Discovery of a new series of Aurora inhibitors through truncation of GSK1070916 by Medina, Jesus R., Grant, Seth W., Axten, Jeffrey M., Miller, William H., Donatelli, Carla A., Hardwicke, Mary Ann, Oleykowski, Catherine A., Liao, Qiaoyin, Plant, Ramona, Xiang, Hong

    Published in Bioorganic & medicinal chemistry letters (15-04-2010)
    “…The SAR results from this investigation will be presented with an emphasis on the impact structural changes have on the cellular phenotype. Novel Aurora…”
    Get full text
    Journal Article
  13. 13

    Benzyl 2-Cyano-3,3-Dimethyl-1-pyrrolidinecarboxylate, a Versatile Intermediate for the Synthesis of 3,3-Dimethylproline Derivatives by Medina, Jesus R, Blackledge, Charles W, Erhard, Karl F, Axten, Jeffrey M, Miller, William H

    Published in Journal of organic chemistry (16-05-2008)
    “…The synthesis of racemic nitrile (±)-9 was accomplished in four steps and 58% overall yield from the known pyrrolidinone 5. Nitrile (±)-9 was resolved via…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    New Direct 11B NMR-Based Analysis of Organoboranes through Their Potassium Borohydrides by Medina, Jesus R, Cruz, Gabriel, Cabrera, Carlos R, Soderquist, John A

    Published in Journal of organic chemistry (13-06-2003)
    “…Representative organoborane mixtures were quantitatively converted to their borohydrides through their reaction with activated KH (KH*), permitting their…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Abstract LB-42: PDK1 knockdown selectively inhibits growth of cancer cells harboring activating mutations involved in MAPK signaling by DeYoung, M. Phillip, Gardiner, Christine M., Chadderton, Antony R., Medina, Jesus R., Axten, Jeffrey M., Rabindran, Sridhar K.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway…”
    Get full text
    Journal Article
  19. 19

    A mild and general method for the synthesis of 2-substituted-5-hydroxypyrimidines by Medina, Jesus R., Henry, Theresa A., Axten, Jeffrey M.

    Published in Tetrahedron letters (09-10-2006)
    “…5-Bromopyrimidines are converted to 5-hydroxypyrimidines using a mild synthetic procedure. The method is general and can be applied to compounds containing…”
    Get full text
    Journal Article
  20. 20

    Abstract LB-116: GSK2334470: A potent and highly selective inhibitor of PDK1 by Axten, Jeffrey M., Medina, Jesus R., Shu, Arthur, Li, William H., Feng, Yanhong, DeYoung, M. Phillip, Gardiner, Christine M., Chadderton, Antony R., Dumble, Melissa, Liu, Qi, Rabindran, Sridhar

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway…”
    Get full text
    Journal Article